Mei Pharma Inc (MEIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
Sales | 65,297 | 48,816 | 40,697 | 34,796 | 27,756 |
Cost of Goods | N/A | N/A | N/A | 1,408 | 2,671 |
Gross Profit | 65,297 | 48,816 | 40,697 | 33,388 | 25,085 |
Operating Expenses | 50,755 | 85,580 | 116,181 | 94,220 | 51,453 |
Operating Income | 14,542 | -36,764 | -75,484 | -60,424 | -25,697 |
Other Income | 3,236 | 4,926 | 21,030 | 19,118 | -21,475 |
Pre-tax Income | 17,778 | -31,838 | -54,454 | -41,306 | -47,172 |
Income Tax | N/A | N/A | N/A | 8 | 1 |
Net Income Continuous | 17,778 | -31,838 | -54,454 | -41,314 | -47,173 |
Net Income | $17,778 | $-31,838 | $-54,454 | $-41,314 | $-47,173 |
EPS Basic Total Ops | 2.67 | -4.78 | -8.75 | -7.40 | -10.40 |
EPS Basic Continuous Ops | 2.67 | -4.78 | -8.75 | -7.34 | -10.36 |
EPS Diluted Total Ops | 2.67 | -4.78 | -9.99 | -12.00 | -10.40 |
EPS Diluted Continuous Ops | 2.67 | -4.78 | -8.70 | -7.22 | -10.36 |
EPS Diluted Before Non-Recurring Items | N/A | -5.02 | -13.40 | -16.80 | -5.20 |
EBITDA(a) | $25,824 | $-36,378 | $-75,158 | $-60,139 | $-25,361 |